AARM 2024 Conference to Feature Dedicated Session on Autism and Cancer
We are pleased to announce a significant addition to the upcoming 1st International Conference on Autism Advanced Research and Management (AARM 2024). A dedicated session on “Preventing, Diagnosing, and Treating Cancer Among People with Autism: From the Bench and the Clinic to Public Health and Policy” will be featured, focusing on the intersection of these two critical areas of health and research.
This session will bring together leading experts in both fields to explore current trends and challenges at the nexus of autism and cancer. The discussion will center on ensuring equal opportunities for autistic individuals diagnosed with cancer, striving to overcome treatment barriers, and eliminating stigma associated with these conditions.
The goal of this session is not only to address these social and medical challenges but also to highlight pioneering research focusing on how cancer affects the autistic population differently. Our experts will delve into topics such as tailored treatment approaches, accessibility of cancer care, and the importance of inclusive health practices that consider the unique needs of autistic individuals.
This special session aims to foster a deeper understanding of both autism and cancer, encouraging a more inclusive and effective approach in medical research and treatment strategies.
- Round Table: “Preventing, Diagnosing, and Treating Cancer Among People with Autism: From the Bench and the Clinic to Public Health and Policy”
- Moderation: Dr. Christos Tsagkaris, Horizon Europe Cancer Mission Board, Brussels, Belgium
Panelists:
Dr. Andreas Koulouris, Karolinska University Hospital, Stockholm, Sweden
Topic: The Oncologist’s Viewpoint: Understanding and Treating Cancer in the Context of Autism Spectrum Disorders
Prof. Eleni (Lina) Tolma, University of Nicosia, Nicosia, Cyprus/Horizon Europe Cancer Mission Board, Brussels, Belgium
Topic: The Public Health Viewpoint: Health Promotion at the Intersection of Cancer and Neurodivergence
Dr. Yeva Margaryan, Institute of Cancer and Crisis, Yerevan, Armenia
Topic: The Syndemic Approach: Preventing and Treating Cancer in People with Neurodivergence in Crisis Settings
Topic: The Health Policy Viewpoint: The Horizon Europe Cancer Mission and the European Approach Towards Quality of Life for Cancer Patients and Survivors
Join us in Athens from September 27-29, 2024, to be part of this vital conversation aimed at fostering a deeper understanding of both autism and cancer. This dialogue is essential for developing more inclusive and effective health solutions across diverse communities.
For the Scientific Committee of the Conference, Professor Athanasios Alexiou, General co-Chair.
For more information or to register for the conference, visit:
Conference website.
Conference registration.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023